Our findings that DKK1 and FRP1, two specific antagonists of Wnt signaling at the level of ligand/receptor interactions [11-14], caused downregulation of active β-catenin levels and TCF transcriptional activity in bone sarcoma cells, strongly implicated an autocrine Wnt signaling loop. Here, HNF4A is linked to bone sarcoma.